MOMEKORT 50 μg/Spray.Nas.Susp.140 Adults, 18 g

Instructions for use for MOMEKORT 50 μg/Spray.Nas.Susp.140 Adults, 18 g

Directions for use of the article "Momekort 50 µg/spray puff nasal spray, Susp.140 for adults". Momekort nasal spray contains the active substance mometasone furoate, which belongs to the group of corticosteroids. It is used to treat hay fever (seasonal allergic rhinitis) in adults after the initial diagnosis has been made by a doctor. Hay fever occurs at certain times of the year and is caused by breathing in pollen. The nasal spray reduces swelling and irritation in the nose, relieving symptoms such as sneezing, itching and a stuffy or runny nose. The recommended dosage is two sprays into each nostril once a day. Once symptoms are under control, the dose can be reduced to 1 spray once a day. Some patients experience symptom relief as early as 12 hours, but full therapeutic benefit may not be achieved for 2 days. Before using the nasal spray for the first time, the bottle should be prepared by actuating the spray 10 times until a fine spray is produced. After 14 days of non-use, the nasal spray should be prepared again. The nasal spray is applied by gently inhaling while spraying into the nose. After use, the nasal piece should be carefully cleaned and the protective cap put on. The nasal spray must not be disposed of in the waste water. Side effects may include nosebleeds, irritation of the nose and throat, burning of the mucous membranes, ulcers of the nasal mucosa, pharyngitis, upper respiratory tract infections and headaches. The medicine contains the active substance mometasone furoate and other excipients such as benzalkonium chloride and glycerol. It is important to note that the medicine is subject to certain contraindications, for example hypersensitivity to the ingredients. Pregnant and breastfeeding women should consult their doctor before use. The nasal spray should be stored at temperatures below 30 °C and it should not be frozen. The nasal spray can be used for 2 months after the first opening. This summary is based on the information in the package leaflet of Momekort Nasal Spray. The package leaflet should be read before use and a doctor or pharmacist should be consulted if there are any questions.